Argus Downgrades Health Management (HMA) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts HMA Hot Sheet
Price: $10.54 --0%
Rating Summary:
4 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
4 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
Argus downgraded Health Management (NYSE: HMA) from Buy to Hold.
For more ratings news on Health Management click here and for the rating history of Health Management click here.
Shares of Health Management closed at $7.97 yesterday.
For more ratings news on Health Management click here and for the rating history of Health Management click here.
Shares of Health Management closed at $7.97 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Argus Downgrades Xylem (XYL) to Hold
- Oppenheimer Downgrades Fidelity National Information Services (FIS) to Perform
- Argus Upgrades Fiserv (FISV) to Buy
Create E-mail Alert Related Categories
DowngradesRelated Entities
ArgusSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
